Reversal of Dabigatran with Idarucizumab in Acute Subarachnoid Hemorrhage
Dabigatran etexilate mesylate is a direct thrombin inhibitor used for reducing the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation. Dabigatran belongs to a new generation of oral agents for anticoagulation – the direct oral anticoagulants (DOACs). The DOACs als...
Збережено в:
| Автори: | , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
eScholarship Publishing, University of California
2017-10-01
|
| Серія: | Clinical Practice and Cases in Emergency Medicine |
| Онлайн доступ: | https://escholarship.org/uc/item/7sj047ms |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|